High altitude physiology full details for md exams 10 marks

For an MD-level exam, a 15-mark answer requires a highly structured, comprehensive, and physiologically precise response. You need to detail the acute, subacute, and chronic adaptations, the molecular mechanisms driving them, and the clinical conditions associated with high-altitude hypoxia. Here is a comprehensive, exam-ready layout designed to maximize your marks, completely formatted for clear presentation. ## 1. Introduction and Physics of High Altitude As altitude increases, the **barometric pressure (PB) decreases exponentially**, while the fractional concentration of oxygen (FiO2) remains constant at **21%**. * **Atmospheric Pressure at Sea Level:** 760 mmHg, which results in an inspired oxygen pressure (PiO2) of approximately 150 mmHg. * **Atmospheric Pressure at Mt. Everest (8848m):** Approximately 253 mmHg, which drops the PiO2 to a critical 43 mmHg. According to **Dalton’s Law**, the partial pressure of inspired oxygen drops drastically, decreasing the pressure gradient between the alveoli and pulmonary capillaries. This triggers **hypobaric hypoxia**, the primary physiological stressor of high altitude. ## 2. The Oxygen Cascade & Hypoxia-Inducible Factor (HIF) The cellular maestro of altitude adaptation is **Hypoxia-Inducible Factor 1-alpha (HIF-1a)**. * **Normoxia:** HIF-1a is hydroxylated by prolyl hydroxylases (PHD) using oxygen, targeted by Von Hippel-Lindau (VHL) protein, and degraded by the proteasome. * **Hypoxia:** PHD is inhibited due to lack of oxygen. HIF-1a stabilizes, translocates to the nucleus, dimerizes with HIF-1b, and binds to **Hypoxia Response Elements (HRE)**. This upregulates genes for erythropoietin (EPO), Vascular Endothelial Growth Factor (VEGF), and glycolytic enzymes. ## 3. Acute and Subacute Physiological Adaptations Adaptation occurs in stages to restore oxygen delivery to tissues. ### A. Respiratory Adaptations (The Hyperventilatory Response) * **Hypoxic Ventilatory Response (HVR):** Peripheral chemoreceptors (carotid bodies) detect a drop in arterial oxygen (PaO2 threshold less than 60 mmHg). They signal the medullary respiratory center via the glossopharyngeal nerve, increasing minute ventilation. * **Respiratory Alkalosis:** Hyperventilation washes out carbon dioxide, causing a drop in arterial carbon dioxide (PaCO2) and a rise in blood pH. * **Central Chemoreceptor Braking:** The rising pH acts as a "brake" on the respiratory center, limiting further hyperventilation. * **Metabolic Compensation (Subacute):** Within 24–48 hours, the kidneys excrete bicarbonate via carbonic anhydrase inhibition to restore blood pH toward normal. This removes the central brake, allowing ventilation to increase further (**Ventilatory Acclimatization**). ### B. Cardiovascular Adaptations * **Sympathetic Surge:** Acute hypoxia stimulates the sympathetic nervous system, increasing circulating catecholamines. This causes an **increase in heart rate (HR) and cardiac output (CO)** to maintain systemic oxygen delivery. Stroke volume remains stable or slightly decreases due to reduced plasma volume. * **Hypoxic Pulmonary Vasoconstriction (HPV):** Unlike systemic vessels which dilate under hypoxia, pulmonary arterioles constrict. This is an intrinsic mechanism to divert blood away from poorly ventilated alveoli. However, at high altitude, *global* HPV occurs, causing **Pulmonary Hypertension** and increasing right ventricular afterload. ### C. Hematological Adaptations and Oxyhemoglobin Curve Shifts * **Hemoconcentration (Acute):** Within hours, hypoxia suppresses aldosterone and stimulates atrial natriuretic peptide (ANP), causing diuresis. Plasma volume drops by up to 20%, artificially elevating hematocrit and hemoglobin concentration to improve oxygen carrying capacity per unit of blood. * **Erythropoiesis (Subacute/Chronic):** HIF-1 mediated release of **Erythropoietin (EPO)** from renal interstitial cells stimulates bone marrow reticulocyte release. True polycythemia develops over weeks. * **Oxyhemoglobin Dissociation Curve Shifts:** * **Acute Shift:** Respiratory alkalosis shifts the curve to the **left**, increasing hemoglobin’s affinity for oxygen in the lungs (facilitating loading). * **Subacute Shift:** Hypoxia increases erythrocyte glycolysis, generating **2,3-Bisphosphoglycerate (2,3-DPG)**. This binds to deoxygenated hemoglobin, shifting the curve to the **right**, facilitating oxygen unloading at tissue levels. > **Key Pathway:** Increased 2,3-DPG leads to a Right Shift, which causes enhanced tissue oxygen delivery. > ### D. Metabolic and Tissue Adaptations * **Mitochondrial Efficiency:** A shift from fatty acid oxidation (which requires more oxygen) to glucose metabolism (which is more oxygen-efficient). * **Angiogenesis:** Tissue-level VEGF expression increases capillary density in skeletal muscle, shortening the diffusion distance for oxygen. ## 4. Summary Table of Physiological Shifts | Organ System | Acute Adaptations (Hours to Days) | Chronic Adaptations (Weeks to Months) | |---|---|---| | **Respiratory** | Hyperventilation, respiratory alkalosis | Restored pH, maximal minute ventilation | | **Cardiovascular** | Increased HR, Increased Cardiac Output, Increased Pulmonary Artery Pressure | Normal CO, Increased Systemic Vascular Resistance, RV hypertrophy | | **Hematological** | Relative polycythemia (diuresis/plasma drop) | Absolute polycythemia (Increased Mass of RBCs), Increased 2,3-DPG | | **Renal** | Increased Bicarbonate excretion (Loss of HCO3-) | Sustained compensation, Increased EPO production | ## 5. High-Altitude Pathophysiology (Clinical Correlations) When acclimation fails or ascent is too rapid, distinct clinical syndromes emerge: ``` [ Rapid Ascent to High Altitude ] │ ┌────────────────────┴────────────────────┐ ▼ ▼ [ Hypoxemia + Alkalosis ] [ Excessive Global HPV ] │ │ ▼ ▼ [ Cerebral Vasodilation ] [ Pulmonary Hypertension ] │ │ ┌──────────┴──────────┐ ▼ ▼ ▼ [ Hydrostatic Transudation ] [AMS] -------------> [HACE] ▼ [HAPE] ``` ### 1. Acute Mountain Sickness (AMS) * **Pathophysiology:** Hypoxia causes cerebral vasodilation to maintain oxygenation, overriding local autoregulation. This increases capillary hydrostatic pressure, leading to mild localized cerebral edema. * **Presentation:** Headache (hallmark), fatigue, dizziness, anorexia, nausea. ### 2. High Altitude Cerebral Edema (HACE) * **Pathophysiology:** An evolution of AMS. Severe hypoxia causes breakdown of the blood-brain barrier (BBB) via VEGF upregulation and cytotoxic/vasogenic edema. * **Presentation:** Ataxia (most sensitive sign), altered mental status, papilledema, coma. ### 3. High Altitude Pulmonary Edema (HAPE) * **Pathophysiology:** Non-cardiogenic pulmonary edema. Uneven, exaggerated **Hypoxic Pulmonary Vasoconstriction (HPV)** creates extreme hydrostatic pressures in over-perfused capillary beds. This causes stress failure of the alveolar-capillary membrane, leading to a protein- and erythrocyte-rich transudative leakage into alveoli. * **Presentation:** Dyspnea at rest, cyanosis, pink frothy sputum, bilateral rales. ### 4. Chronic Mountain Sickness (Monge's Disease) * Occurs in long-term high-altitude residents. Characterized by severe over-adaptation: extreme polycythemia (Hematocrit greater than 65%), severe pulmonary hypertension, cyanosis, and right heart failure (Cor Pulmonale) due to blood hyperviscosity. ## 6. Management Principles * **Gold Standard:** Immediate, safe **descent**. * **Oxygen Therapy:** Hyperbaric chambers (Gamow bags) if descent is impossible. * **Pharmacotherapy:** * **Acetazolamide:** A carbonic anhydrase inhibitor. Forces renal bicarbonate excretion, inducing metabolic acidosis. This stimulates the central chemoreceptors to eliminate the respiratory "brake," accelerating acclimatization. * **Dexamethasone:** Potent steroid used to reduce brain swelling in HACE and severe AMS. * **Nifedipine / Phosphodiesterase-5 Inhibitors (Sildenafil):** Pulmonary vasodilators used to mitigate HPV in HAPE.

What's the difference